SOUTH PORTLAND, ME and PHILADELPHIA – March 13, 2023 – Proscia®, a leading provider of digital and computational pathology solutions, today announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq® Dx to modernize its pathology operations. In adopting Proscia’s software platform, SHCP will increase access to high-quality diagnostic services across Maine and New Hampshire, better informing treatment decisions for more patients.
Digital pathology, which shifts the 150-year-old standard of care from microscope to whole slide image, is democratizing diagnostic services for diseases like cancer at a time when an intensifying workforce shortage is putting added pressure on laboratories to keep pace with rising biopsy volume. As SHCP serves patients across various healthcare systems, it recognized an opportunity to pioneer the use of digital pathology in its region to expand the reach of its subspecialist experts and deliver timely results.
“We believe that all patients, regardless of geography, deserve access to high-quality care,” said Bilal R. Ahmad, MD, MBA, FCAP, Managing Director, Pathology Division at Spectrum Healthcare Partners. “Concentriq Dx is critical to decentralizing our diagnostic services. It will enable us to seamlessly transition to digital pathology at scale so that we can reimagine our day-to-day operations beyond the confines of our physical laboratory spaces.”
Concentriq Dx* is a modern digital pathology platform that drives diagnostic workflows for laboratory networks of all sizes. By streamlining collaboration and enabling remote image viewing, it provides faster, broader access to subspecialist experts, helping more patients to begin the best treatment sooner. The platform also offers world-class interoperability with leading scanners and image analysis applications and is designed for realizing the promise of pathology’s AI-powered future to meet evolving needs.
“We are excited to welcome Spectrum Healthcare Partners to the growing roster of hospital systems and diagnostic laboratories adopting Concentriq Dx,” said David West, Proscia’s CEO. “Our organizations share a strong commitment to the patient, and we are thrilled that SHCP sees the value of modern digital pathology in democratizing diagnosis and helping to improve treatment decisions.”
To learn more about how Concentriq Dx will help SHCP to advance its pathology practice and see a live demonstration of the platform, visit Proscia at booth #510 during the USCAP 112th Annual Meeting.
*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency.
About Spectrum Healthcare Partners
Spectrum Healthcare Partners (SHCP) is the largest multispecialty, physician-owned group practice in Maine, serving patients across all of Maine and New Hampshire. The organization consists of 200 physicians practicing in the areas of anesthesiology, orthopaedics, pathology, radiation oncology, radiology, and vascular and interventional radiology. SHCP partners with hospitals and healthcare organizations throughout northern New England to provide high-value services. For more information, visit SpectrumHCP.com.
About Proscia
Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and 14 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.